The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa.

BACKGROUND AND AIMS: People who inject drugs (PWID) are a key population at high risk of hepatitis C virus (HCV) infection. The aim of this study was to delineate the epidemiology of HCV in PWID in the Middle East and North Africa (MENA). METHODS: Syntheses of data were conducted on the standardized and systematically assembled databases of the MENA HCV Epidemiology Synthesis Project, 1989-2018. Random-effects meta-analyses and meta-regressions were performed. Meta-regression variables included country, study site, year of data collection and year of publication [to assess trends in HCV antibody prevalence over time], sample size and sampling methodology. Numbers of chronically infected PWID across MENA were estimated. The Shannon Diversity Index was calculated to assess genotype diversity. RESULTS: Based on 118 HCV antibody prevalence measures, the pooled mean prevalence in PWID for all MENA was 49.3% [95% confidence interval (CI) = 44.4-54.1%]. The country-specific pooled mean ranged from 21.7% (95% CI = 4.9-38.6%) in Tunisia to 94.2% (95% CI = 90.8-96.7%) in Libya. An estimated 221 704 PWID were chronically infected, with the largest numbers found in Iran at 68 526 and in Pakistan at 46 554. There was no statistically significant evidence for a decline in HCV antibody prevalence over time. Genotype diversity was moderate (Shannon Diversity Index of 1.01 out of 1.95; 52.1%). The pooled mean percentage for each HCV genotype was highest in genotype 3 (42.7%) and in genotype 1 (35.9%). CONCLUSION: Half of people who inject drugs in the Middle East and North Africa appear to have ever been infected with hepatitis C virus, but there are large variations in antibody prevalence among countries. In addition to > 200 000 chronically infected current people who inject drugs, there is an unknown number of people who no longer inject drugs who may have acquired hepatitis C virus during past injecting drug use. Harm reduction services must be expanded, and innovative strategies need to be employed to ensure accessibility to hepatitis C virus testing and treatment

An ethnic model along differentiation between justified death attitude and polls in a cross-cultural generational study

Background: “Justified Death Attitude (JDA) is imminent and likely paradoxical behavior against self threat to keep of self in modification for elimination of the opponent mentally or physically”the first author defined. The former studies have indicated that Justified Death Attitude Scale (JDAS) has both validity and reliability of the young majority society Shia, but we do not know whether or not it is a valid or reliable scale of minority societies Sunni, Assyrian and the old generation. If it has, can the scale discriminate between the JDA and the poll? Objectives: It is a cross-sectional study to evaluate development of JDAS comprehensively because different generations, multi ethnicities, and social variables affect attitude and cognition persistently. Method: 744 participants (368 male and 376 female) were selected through the convenience sampling method in Tehran, Ilam, Khoram Abad, and Sanandaj. The participants were of the following demographic properties: 528 adult and 216 older adult participants; 538 Shia, 108 Sunni, and 98 Assyrian participants; 460 normal and 284 abnormal participants. Participants carried out the General Health Questionnaire-12 (GHQ-12) and JDAS. 115 answer sheets were cancelled (less than 5%). Results: A Pearson product-moment correlation coefficient, binomial tests, Chi square tests, and Jonckheere-Terpstra tests are performed to analyze the data. Multiethnic studies indicate that JDAS is a valid scale for adult and older adult participants and Shia, Sunni, and Assyrian participants (p>0.05). Meanwhile, attitude and polls are two different phenomena in the collision between capital punishment, the kind of death penalties, the agreement of euthanasia, and kind of euthanasia %61, %57, %56, and %61, respectively, because of different propositional and associative processes. The Chi-square indicates that gender, generations, ethnics, and sanity influence polls significantly. In line with the ethnic model of JDA, ethnics influence legal and medical subscales significantly according to Jonckheere-Terpstra tests. Conclusion: The bases of polls and attitude are conformity and self, respectively. So, the poll coefficient of error is very high to assess social ideas. Although you could find some similarities between polls and attitude, they are different phenomena principally

The Influences of Ethnicity, Gender, Generation, and Mental Health over Justified Death Attitude

Background: Justified Death Attitude (JDA) is a new term about one’s agreement with killing someone else. Previous studies have shown the Justified Death Attitude Scale (JDAS) is valid and reliable. We also know that some variables like major and gender are associated with JDA, but we do not know how gender, ethnics, generation, and sanity differently would affect JDA. Objectives: This was a cross-sectional study to evaluate the effect of ethnics, generation, gender, and sanity on the attitude of the people about justified death. Method: In 2022, 744 participants, including 368 male and 376 female participants were selected through convenience sampling method in Tehran, Ilam, Khorramabad, and Sanandaj. Participants were stratified according to age (528 adults, 216 older adults), religion (538 Shiite, 108 Sunni, and 98 Assyrian participants), and sanity status (460 normal and 284 participants with possible mental illness). Participants filled out General Health Questionnnair-12 (GHQ 12) and Justified Death Attitude Scale (JDAS). Results: Older, Shiite, and Sunni participants agreed more with death penalties, but younger and Assyrian participants disagreed more with death penalties. Furthermore, young, Assyrian agreed more often with euthanasia. Different generations think significantly differently about the type and severity of execution and euthanasia. Conclusion: The more diverse the sociocultural background, the more different is the attitude about justified death. That might be due to dissimilar crystallization of sense of self in different socio-cultural backgrounds and through different cognitive processes

Severity and mortality of COVID-19 infection in HIV-infected individuals: Preliminary findings from Iran

Background: Higher mortality due to coronavirus disease 2019 (COVID-19) is reported among some immunocompromised patients; however, the relation between immunosuppression due to HIV infection and severity of COVID-19 infection remains unclear. We aimed to investigate the severity and mortality of COVID-19 infection in HIV-infected patients. Methods: This was a retrospective cohort study on all COVID-19 suspected and confirmed cases hospitlized in Iran between Febuary 19 (epidemic onset date) and April 8, 2020, whose data were recorded in the national database for Medical Care Monitoring Center. Hospitalized patients were followed from admittion to death/discharge. Patients� HIV status was recorded based on their self report. Logistic and Cox regression models were used to evaluate the association between HIV infection and the severity (according to the Glascow-Coma Scale situation, need for intubation and hypoxemia) and mortality of COVID-19 infection, respectively. Analyses were performed separately for COVID-19 suspected and confirmed cases. Results: Out of 122 206 severe acute respiratory infection (SARI) cases, 90 were HIV-positive (0.07), with a similar mean age (Pttest= 0.750) and distrubtion of gender (PChi-square= 0.887) and nationality (PChi-square= 0.202) as HIV-negative patients. A comparable proportion of HIV-positive and HIV-negative cases were tested for COVID-19 (p= 0.170); however, the frequency of positive results was lower among HIV-positives (p= 0.038). The frequency of COVID-19 and HIV coinfection was lower than expected among confirmed cases (adjusted OR= 0.54; 95 CI: 0.29-1.02) and suspected cases (adjusted OR= 0.68; 95 CI: 0.45- 1.02), which means that the frequency of COVID-19 infection was lower among HIV-positive cases. HIV infection decreased the risk of death among confirmed (adjusted HR= 0.33; 95 CI: 0.05-2.32), suspected cases (adjusted HR= 0.81; 95 CI: 0.33-1.94), and among SARI cases (adjusted HR= 0.73; 95 CI: 0.35-1.54). Conclusion: Our findings support the concept that HIV infection was not a risk factor to increase the severity and risk of death among COVID-19 infected patients. Copyright© Iran University of Medical Science

Hiv/aids surveillance system in the islamic Republic of Iran: History, structures and processes

Background and Objectives: Iran is one of the Middle Eastern countries that implemented the HIV / AIDS control and surveillance program many years ago. The purpose of this study was to review the HIV / AIDS surveillance system in Iran.   Methods: This was a review research to assess the processes, structures and achievements of the HIV/AIDS surveillance system in Iran. The information sources of this study included data from the surveillance system, reports and documentation, and published guidelines, reviewing existing structures and views of managers and practitioners of the HIV/AIDS surveillance system in Iran.   Results: In Iran, all cases with HIV / AIDS as well as people with high risk behaviors are referred to behavioral disease counseling centers in order to receive health care services. Harm reduction in people with risky behaviors in the form of counseling centers, drug addictschr('39') centers, and womenchr('39')s counseling centers in collaboration with governmental and non-governmental organizations, and attention to the second generation of HIV/AIDS surveillance, particularly conducting behavioral studies, are other components of the HIV / AIDS surveillance system in Iran   Conclusion: Although the HIV / AIDS surveillance system in Iran has a large structure with many achievements in reducing new HIV cases, especially in some high-risk groups such as injecting drug users, as well as reducing HIV transmission from infected mothers to their children, strengthening this surveillance system, especially for sexual high-risk groups, is essential for controlling HIV/AIDS in the country

HIV-1 drug resistance mutations detection and HIV-1 subtype G report by using next-generation sequencing platform

Background: Based on world health organization (WHO) recommend, drug resistance assay should be performed in initial of treatment and after treatment for administering and monitoring of anti-retroviral regime in HIV-1 infected patients. Material and method: NGS analyses were performed on forty-one plasma samples from HIV-1 affected patients using the Sentosa SQ HIV genotyping assay (Vela-Diagnostics, Germany). This system comprises a semi-automated Ion torrent based platform and the sequencing results were analyzed based on ANRS, REGA and Stanford drug resistance algorithms. Phylogenetic analysis was analyzed based on https://comet.lih.lu database as well as MEGA5 Software. Results: Drug resistances were identified in thirty-three samples (80) out of forty-one samples. The Phylogenetic analysis results showed that CRF-35AD (94) and subtypes B (2.4) and G (2.4) were dominant subtypes in this study. NRTI and NNRTI associated dominant mutations were M184I/V and K103 N.High-level resistance to lamivudine (3 TC) and Emtricitabine (FTC) were detected in 34.3 of patients while 53.1 were resistant to Efavirenz (EFV) and Nevirapine (NVP). The Protease inhibitor (PI) minor and major mutations were not reported but more than 95 of samples had polymorphisms mutation in K20R, M36I, H69K, L89 M positions. These mutations are subtype dependent and completely are absent in subtype B virus. The secondary mutations were reported in positions of E157Q, S230 N, and T97A of integrase gene and four samples represent low-level resistance to integrase strand transfer inhibitor (INSTI). Conclusions: This is the first preliminary evaluation of HIV-1 drug resistance mutation (DRM) by using the Sentosa SQ HIV Genotyping Assay in Iran. The NGS represent a promising tool for the accurate detection of DRMs of CRF-35AD that is dominant subtype in Iranian HIV-1 infected population and for the first time revealed HIV-1 subtype G in Iranian population. In the present study polymorphic mutation in the position of K20R, M36I, H69K, L89 M were properly reported in CRF35AD that is dominant in Iranian HIV patients. © 202

Single-pill sofosbuvir and daclatasvir for treating hepatis C in patients co-infected with human immunodeficiency virus

Background: The current recommendation for treating hepatitis C virus (HCV) in HIV patients includes the combination of sofosbuvir (SOF) and daclatasvir (DCV). DCV should be used at different doses to compensate for interactions with antiretroviral therapy (ART). Up to three pills a day might be required which will significantly add to the pill burden of these patients. In this study, we have used a single-tablet approach to treating HCV-HIV coinfection. Methods: Patients coinfected with HIV and HCV were prospectively enrolled from 10 centers throughout the country. Patients received a single once-daily fixed dose combination (FDC) pill containing 400 mg SOF and 30, 60 or 90 mg DCV depending on the type of ART they were receiving for 12 or 24 weeks. (ClinicalTrials.gov ID: NCT03369327). Results: Two hundred thirty-three patients were enrolled from 10 centers. Twenty-three patients were lost to follow-up and two patients died from causes unrelated to treatment. Two hundred eight patients completed the treatment course of which 201 achieved SVR (96.6). Conclusion: Single-tablet combination of DCV and SOF is an effective and safe treatment for patients coinfected with HIV and HCV. The combination works well in patients on ART in which dose adjustment is required. Patients with cirrhosis, previous treatment failure and various genotypes respond identically. The expenses of genotyping can be saved. © 2021 John Wiley & Sons Lt